Therefore, the treatment with TMZ is found to be very effective in brain tumors with methylated MGMT promoter, i.e. in the secondary glioblastoma, as it plays a critical factor for the efficacy of TMZ [35]. This evidence concerns the gene MGMT and brain neoplasm.